In a study of over 17,000 people, semaglutide, a GLP-1 receptor agonist medication, was found to lower the risk of cardiovascular events like heart attacks and strokes by 20% in people who have pre-existing cardiovascular disease and who are overweight, but do not have Type 2 diabetes
On cost-per-evidence, injectable compounded wins
Whilst there is no official guidance on optimal injection timing, some individuals report fewer symptoms when administering Wegovy in the evening rather than the morning
Getting the dosage right is crucial to managing potential side effects and ensuring a smoother journey towards achieving your goals
Since involvement is voluntary, there are no charges, and there are no fees after every month
Adjusting macronutrient ratios toward higher protein and moderate carbohydrate intake can improve satiety and support lean mass